ORGANOGENESIS HOLDINGS INC. Operating Cash Flow
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Operating Cash Flow of -$10.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$31.65M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $21.13M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $39.42M, a 260.43% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $3.08M, a 64.59% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2025 was -$10.31M, a 172.56% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2024 was $14.21M, a 54.04% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2023 was $30.92M, a 24.37% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) operating activities for fiscal 2022 was $24.86M, a 59.89% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$31.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.53M 10-Q · filed 2026-08-06 | $28.89M derived: sum of 3 quarters · filed 2026-08-06 | $31.97M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $21.13M 10-Q · filed 2026-05-07 | $60.55M derived: sum of 2 quarters · filed 2026-05-07 | $63.63M derived: sum of 3 quarters · filed 2026-05-07 | $30.75M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $39.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.50M derived: sum of 2 quarters · filed 2026-02-26 | $9.63M derived: sum of 3 quarters · filed 2026-08-06 | -$10.31M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$29.79M derived: sum of 2 quarters · filed 2026-08-06 | -$49.73M 10-Q · filed 2025-11-06 | -$38.79M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | -$32.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$52.81M 10-Q · filed 2026-08-06 | -$41.87M derived: sum of 3 quarters · filed 2026-08-06 | -$33.18M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | -$19.93M 10-Q · filed 2026-05-07 | -$9.00M derived: sum of 2 quarters · filed 2026-05-07 | -$303.00K derived: sum of 3 quarters · filed 2026-05-07 | $4.43M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $10.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.63M derived: sum of 2 quarters · filed 2026-02-26 | $24.37M derived: sum of 3 quarters · filed 2026-02-26 | $14.21M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $8.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.43M derived: sum of 2 quarters · filed 2025-11-06 | $3.27M 10-Q · filed 2025-11-06 | $13.88M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.42M 10-Q · filed 2025-08-07 | $5.19M derived: sum of 3 quarters · filed 2026-02-26 | $21.92M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | -$10.16M 10-Q · filed 2025-05-08 | $452.00K derived: sum of 2 quarters · filed 2026-02-26 | $17.19M derived: sum of 3 quarters · filed 2026-02-26 | $25.83M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | $10.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.35M derived: sum of 2 quarters · filed 2026-02-26 | $35.99M derived: sum of 3 quarters · filed 2026-02-26 | $30.92M 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | $16.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $25.38M derived: sum of 2 quarters · filed 2024-11-12 | $20.30M 10-Q · filed 2024-11-12 | $20.30M 10-Q · filed 2023-11-09 | $28.10M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $8.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.57M 10-Q · filed 2024-08-08 | $11.37M derived: sum of 3 quarters · filed 2025-02-27 | $16.82M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-03-31 | -$5.08M 10-Q · filed 2024-05-09 | $2.72M derived: sum of 2 quarters · filed 2025-02-27 | $8.18M derived: sum of 3 quarters · filed 2025-02-27 | $18.37M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.25M derived: sum of 2 quarters · filed 2025-02-27 | $23.45M derived: sum of 3 quarters · filed 2025-02-27 | $24.86M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $15.65M derived: sum of 2 quarters · filed 2023-11-09 | $17.06M 10-Q · filed 2023-11-09 | $35.01M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $11.61M 10-Q · filed 2023-08-09 | $29.55M derived: sum of 3 quarters · filed 2024-02-29 | $57.40M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-03-31 | $1.41M 10-Q · filed 2023-05-10 | $19.36M derived: sum of 2 quarters · filed 2024-02-29 | $47.21M derived: sum of 3 quarters · filed 2024-02-29 | $64.69M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2021-12-31 | $17.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $45.80M derived: sum of 2 quarters · filed 2024-02-29 | $63.28M derived: sum of 3 quarters · filed 2024-02-29 | $61.98M 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $27.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $45.33M derived: sum of 2 quarters · filed 2022-11-09 | $44.03M 10-Q · filed 2022-11-09 | $67.25M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-06-30 | $17.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $16.18M 10-Q · filed 2022-08-09 | $39.40M derived: sum of 3 quarters · filed 2023-03-01 | $48.26M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-03-31 | -$1.30M 10-Q · filed 2022-05-10 | -$1.48M 10-Q · filed 2021-05-11 | $21.91M derived: sum of 2 quarters · filed 2023-03-01 | $30.78M derived: sum of 3 quarters · filed 2023-03-01 | $21.45M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $23.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $32.08M derived: sum of 2 quarters · filed 2023-03-01 | $22.75M derived: sum of 3 quarters · filed 2023-03-01 | $5.47M 10-K · filed 2023-03-01 | $6.80M 10-K · filed 2021-03-16 | ||||
| 2020-09-30 | $8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$466.00K derived: sum of 2 quarters · filed 2021-11-09 | -$17.75M 10-Q · filed 2021-11-09 | -$19.48M 10-Q · filed 2020-11-09 | -$24.15M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$9.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$26.62M 10-Q · filed 2021-08-09 | -$33.02M derived: sum of 3 quarters · filed 2022-03-01 | -$38.47M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | -$17.28M 10-Q · filed 2021-05-11 | -$23.68M derived: sum of 2 quarters · filed 2022-03-01 | -$29.14M derived: sum of 3 quarters · filed 2022-03-01 | -$41.25M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$11.85M derived: sum of 2 quarters · filed 2022-03-01 | -$23.97M derived: sum of 3 quarters · filed 2022-03-01 | -$33.53M 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | -$5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$17.57M derived: sum of 2 quarters · filed 2020-11-09 | -$27.13M 10-Q · filed 2020-11-09 | -$44.53M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-06-30 | -$12.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$21.67M 10-Q · filed 2020-08-10 | -$39.08M derived: sum of 3 quarters · filed 2021-03-16 | -$62.07M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-03-31 | -$9.56M 10-Q · filed 2020-05-11 | -$26.96M derived: sum of 2 quarters · filed 2021-03-16 | -$49.95M derived: sum of 3 quarters · filed 2021-03-16 | -$65.74M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2018-12-31 | -$17.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$40.40M derived: sum of 2 quarters · filed 2021-03-16 | -$56.18M derived: sum of 3 quarters · filed 2021-03-16 | -$60.63M 10-K · filed 2021-03-16 | -$60.74M 10-K · filed 2019-03-18 | ||||
| 2018-09-30 | -$22.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$38.77M derived: sum of 2 quarters · filed 2019-11-12 | -$43.23M 10-Q · filed 2019-11-12 | -$723.18K 10-Q · filed 2018-11-09 | -$46.23M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-06-30 | -$15.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$20.24M 10-Q · filed 2019-08-09 | -$436.48K 10-Q · filed 2018-08-07 | -$23.24M derived: sum of 3 quarters · filed 2020-03-09 | -$23.40M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-03-31 | -$4.46M 10-Q · filed 2019-05-10 | -$226.39K 10-Q · filed 2018-05-10 | -$7.46M derived: sum of 2 quarters · filed 2020-03-09 | -$7.62M derived: sum of 3 quarters · filed 2020-03-09 | -$7.82M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2017-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$3.17M derived: sum of 2 quarters · filed 2020-03-09 | -$3.37M derived: sum of 3 quarters · filed 2020-03-09 | -$3.49M 10-K · filed 2020-03-09 | -$586.60K 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | -$168.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$368.47K derived: sum of 2 quarters · filed 2018-11-09 | -$494.76K 10-Q · filed 2018-11-09 | -$5.34M derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2017-06-30 | -$199.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$326.03K 10-Q · filed 2018-08-07 | $48.97K 10-Q · filed 2017-08-11 | -$5.17M derived: sum of 3 quarters · filed 2019-03-18 | |||||
| 2017-03-31 | -$126.29K 10-Q · filed 2018-05-10 | -$4.97M derived: sum of 2 quarters · filed 2019-03-18 | |||||||
| 2016-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$4.87M 10-K · filed 2019-03-18 | -$562.23K 10-K · filed 2018-03-14 | ||||||
| 2016-09-30 | -$24.49K 10-Q · filed 2017-11-14 | ||||||||
| 2015-12-31 | -$16.69K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |